BRUNSWICK, Maine — The side effects of any new pharmaceutical drug can often be scarier than what they’re meant to treat; but how can drug companies do better testing?

They can start with a company called InSphero. Armand Wolf, the Chief Scientific Officer for the company, spent years working in drug development in the pharmaceutical field.

“Most of the drugs, when they’re just reaching clinical phase, 90% of them are failing,” says Wolf. Those drugs are failing – on average – 10 years into testing. “It will cost about $1-2 Billion, so this is a huge waste of money.” Read more